Holmium laser enucleation versus photoselective vaporization for prostatic adenoma greater than 60 ml: Preliminary results of a prospective, randomized clinical trial, "Beyond the Abstract," by Mostafa Elhilali, OC, OQ, MD, PhD, FRCSC

BERKELEY, CA (UroToday.com) - I would like to underline the fact that the 532 nm laser used was the GreenLight HPS® system. This is a 120-watt system with less than desired hemostatic properties and might have contributed to the higher than expected conversion rates. Since last year we have been using the newer version (GreenLight XPS™ 180-watt) that has, as one of its features, a true coagulation mode which is pulsatile and provides a more effective way of reducing bleeding.

We are presently redoing a similar randomized study comparing the XPS™ system and HOLEP in large prostates, and we hope to present that next year.

 

Written by:
Mostafa Elhilali, OC, OQ, MD, PhD, FRCSC as part of Beyond the Abstract on UroToday.com. This initiative offers a method of publishing for the professional urology community. Authors are given an opportunity to expand on the circumstances, limitations etc... of their research by referencing the published abstract.

Professor of Surgery
Stephen Jarislowsky Chair of Urology
McGill University
Royal Victoria Hospital
687 Pine Ave. West, Room S6.95
Montreal, Quebec H3A 1A1
Email:

Holmium laser enucleation versus photoselective vaporization for prostatic adenoma greater than 60 ml: Preliminary results of a prospective, randomized clinical trial - Abstract

More Information about Beyond the Abstract